Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Head-to-head comparison of BPC-157 and TB-500 — mechanism, dosing, side effects, legal status, and pricing.
BPC-157 is a synthetic pentadecapeptide derived from a protective protein found in human gastric juice. It is widely studied for its tissue-healing properties, including tendon, ligament, muscle, and gut repair.
TB-500 is a synthetic fragment of thymosin beta-4, a naturally occurring protein involved in cell migration, proliferation, and differentiation. It is studied for wound healing, tissue repair, and reduction of inflammation.
BPC-157
TB-500
Category
Legal Status
Mechanism
Dose Range
Route
Frequency
Dosing Notes
Side Effects
Contraindications
Extensive preclinical research in rodent models demonstrates accelerated healing of tendons, ligaments, muscles, and the gastrointestinal tract. Human clinical trials are limited but underway. It remains one of the most studied peptides in regenerative medicine.
Animal studies show significant benefits in wound healing, cardiac repair post-infarction, and corneal repair. Clinical trials are limited. TB-500 has been used extensively in equine veterinary medicine for injury recovery.
BPC-157 and TB-500 are both in the Recovery category and may have overlapping mechanisms. Researchers should review both profiles carefully, understand the mechanisms of action, and monitor the relevant biomarkers when combining compounds in the same class. As always, consult a licensed healthcare provider before making any decisions about combining research compounds.
This platform provides informational tools only, not medical advice. This comparison is for educational purposes only. Consult a licensed provider.
Disclosed Labs